Niko Andre is the Global Head of Immuno-Oncology and Haematology at AstraZeneca, based in Switzerland.
Niko is a passionate advocate for improved cancer care. He pursued his medical degree and PhD at the University of Hamburg, Germany and continued his medical career in Germany and the US. As an experienced oncology researcher and treating physician, Niko is adept at translating science into tangible value for patients and effectively collaborating with research and development and with policy.
Niko joined AstraZeneca in 2020. He is a proven leader who brings together profound experience in science, clinical medicine and commercial operations in the life science industry. Niko has contributed to building AstraZeneca’s position in oncology leading the Haematology business and now the expansion of the Immuno-Oncology portfolio. Before joining AstraZeneca, he led Roche’s Global Medical Affairs group across all therapeutic areas, following earlier assignments as Global Medical Head Oncology/Hematology and German Medical Director Oncology/Hematology.
Niko is an active member of ASCO, AACR, ESMO and the German Cancer Society, maintaining a global network of cancer specialists, advocates and industry leaders. He is eager to collaborate at every possible level towards better outcomes for cancer patients.
Updated: October 2021